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1. Introduction
Terrestrial and marine plants, animals, fungi, and bacteria
(among others) are known to produce a multitude of
secondary metabolites, often referred to as “natural prod-
ucts.”[1] In contrast to the required production of primary
metabolites to sustain life, organisms can generally survive
without the production of secondary metabolites; however,
these metabolites often aid in the reproductive and/or
defensive efforts of the species that produce them.[2,3] From
a medicinal standpoint, many natural products also provide
a rich source of bioactive agents, such as antitumor, anti-
bacterial, anti-insecticidal, anthelmintic, antinematodal,
immunosuppressives, as well as other clinically relevant
activities, which have been widely exploited for both synthetic
and semisynthetic drug discovery and development efforts.[4,5]
In the vast majority of cases, chiral natural products are
produced in nature in optically pure form, with only one
enantiomer biosynthesized in the producing organism.[1,6] For
example, only the biologically active () isomer of morphine
is produced by nature, specifically by the opium poppy plant
Papaver somniferum.[7] On the other hand, the production and
isolation of enantiomeric metabolites is known, but remains
a rare occurrence relative to the overall abundance of
secondary metabolites. These enantiomerically opposite
metabolites can be produced by different genera or species,
with one enantiomer being isolated from one species and the
other enantiomer from a different species or genera. Some-
times both enantiomers may also be produced and isolated as
either a racemic or scalemic mixture (where one enantiomer
predominates) from a single species.[6a]
Efforts to elucidate the biosynthetic pathway of bioactive
natural products have been an area of intense research for
over 75 years for both organic chemists and biologists.[2,4]
However, the biogenesis of enantiomeric metabolites is
generally not well understood. This is due in part to the fact
that often one enantiomer always predominates over the
other in nature, as is the case with ()-nicotine,[8] and in many
other instances, the other natural enantiomer may be
discovered years or decades later. As a result, the biosynthesis
of the major and sometimes more bioactive enantiomer is
well-studied, while the biosynthesis of the minor enantiomer
remains unknown.
This Review is intended to provide an overview of the
occurrence of well-known enantiomeric natural products
produced in nature, and to present a discussion, when
applicable, of how these rare enantiomerically opposite
metabolites arise biosynthetically. As a consequence of the
overwhelming number of known secondary metabolites, and
the often overlooked reporting of the optical rotation or CD
spectra of similar substances obtained from different sources,
not all the enantiomeric natural products have been identi-
fied. Furthermore, despite decades of research, not all of the
biosynthetic pathways for the formation of enantiomeric
natural products are fully understood; therefore, biogenetic
discussions will focus on those metabolites where substantial
and relevant biosynthetic research has been carried out. This
Review is organized into classes of secondary metabolites on
the basis of their main biosynthetic derivations: terpenes
(isoprene), phenylpropanoids (shikimic acid), polyketides
(acetate), and alkaloids (amino acids). In many cases, these
partitions are superficial since many natural products are
often of mixed biosynthetic origins (for example, the terpe-
noid alkaloids or mixed polyketide-nonribosomal peptide
metabolites).
2. Terpenes
The terpenes are a large group of structurally diverse
natural products of well over 30000 compounds.[9,10] Typically
isolated from a wide variety of plant species, these secondary
metabolites display myriad biological activities, ranging from
pollinator attractants and chemical defenses for plants to
essential oils and anticancer drugs for human clinical use.[10]
In nature, chiral natural products are usually produced in optically
pure form—however, occasionally both enantiomers are formed.
These enantiomeric natural products can arise from a single species or
from different genera and/or species. Extensive research has been
carried out over the years in an attempt to understand the biogenesis of
naturally occurring enantiomers; however, many fascinating puzzles
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All terpenoids are constructed from the head-to-tail con-
densation of repeating C5 isoprene units and are further
subdivided into families on the basis of the number of
isoprenoid residues. The monoterpenes (C10) are the smallest
structural type, followed by the sesquiterpenes (C15), diter-
penes (C20), sesterterpenes (C25), triterpenes (C30), tetrater-
penes (C40), and polyterpenes (>C40).
Enantiomeric terpenoids are (in a relative sense) rather
common; however, they are generally limited to monoter-
penes, sesquiterpenes, and, on rare occasions, diterpenes.
Currently, (+)- and ()-wistarin are the only examples to date
of enantiomeric sesterterpenes (Figure 1), and the biosyn-
thetic formation of these enantiomers is yet to be inves-
tigated.[11] Extensive research has been put forth toward
determining the biosynthesis of enantiomeric monoterpenes,
and while the biosynthesis of sesquiterpenes and diterpenes is
understood, there are several unanswered questions about the
formation of enantiomerically opposite secondary metabo-
lites.
2.1. Monoterpenes
Compounds from the C10 monoterpene family of secon-
dary metabolites are mainly isolated from higher plants and
make up the flavor and aroma components of many essential
oils of herbs, spices, citrus, and conifers.[12] The biosynthesis of
monoterpenes has been thoroughly investigated by isotope
studies with enzyme preparations and the isolation of cDNAs
encoding monoterpene synthases;[13] however, not all of the
biosynthetic routes leading to the monoterpenes are fully
understood.
Over the years, considerable attention has been placed
specifically on the stereochemistry and mechanism of the
cyclization reactions.[10,13a,14,15] Decades of research have
established that monoterpene synthases are responsible for
the formation of acyclic, monocyclic, and bicyclic monoter-
penes, and that each synthase is capable of generating
multiple products at the same active site. Since the co-
occurrence of both monoterpene enantiomers in the same
species is fairly common, interest has focused on determining
how these enantiomers arise biosynthetically. With the
isolation and characterization of numerous cyclases from
Salvia, Mentha, Tanacetum, Foeniculum, Pinus, and Citrus
species, including (+)-limonene synthase fromMentha piper-
ita (peppermint), ()-limonene synthase from Carum carvi L.
(caraway seeds), and (+)- and ()-a-pinene synthases from
Salvia officinalis (sage), it was determined that monoterpene
enantiomers can arise independently by stereochemically
distinct routes. However, not all monoterpene synthases are
completely stereospecific, as observed in the ()-limonene
synthase isolated from caraway seeds (see Section 2.1.1).[10,13a]
The sizeable amount of research that has been carried out
on the monoterpenes has led to the formation of a widely
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accepted mechanism for the monoterpene cyclization reac-
tion (Scheme 1).[10,13a] To start, geranyl diphosphate (GPP)
binds stereoselectively in the active site as either a right-
handed or left-handed helical conformer. GPP then under-
goes ionization and isomerization to afford either (3R)- or
(3S)-linalyl diphosphate (LPP). The enzyme-bound (3R)- or
(3S)-LPP then undergoes a second ionization that initiates the
C6-C1 cyclization to afford the a-terpinyl cation in either the
4R or 4S form. From this universal monocyclic intermediate,
a plethora of mechanisms (further electrophilic cyclization,
hydride shifts, or Wagner–Meerwein rearrangements) are
possible for the formation of the various monoterpene
skeletons, with a final deprotonation or nucleophilic capture
terminating the sequence.
As shown in Table 1, many of the chiral monoterpenes are
produced in both enantiomeric forms, often by the same plant
species. Additionally, many of the enantiomeric monoter-
penes display unique biological activities, oftentimes with
each enantiomer exhibiting distinct biological properties.
Efforts to elucidate the biosynthetic formation of enantio-
meric monoterpenes have been greatly aided by the isolation
and characterization of several monoterpene synthases. Dis-
cussed below are three well-studied enantiomeric monoter-
pene biosyntheses (limonene, carvone, and a-pinene) for
which distinct stereospecific
enzymes have been identi-
fied that catalyze the cycli-
zation of GPP to the corre-
sponding monoterpene ole-
fins of opposite configura-
tions.
2.1.1. Limonene and Carvone
Limonene is a widely
distributed cyclic monoter-
pene and is a common pre-
cursor to the p-menthane
family of natural products,
as well as to the known
monoterpene carvone. Both
limonene and carvone are
unique from a bioactivity
perspective, in that each
enantiomer exhibits a dis-
tinct scent. Perhaps the
most well-known example
of this is that (+)-carvone
smells of caraway, while its
enantiomer produces
a spearmint odor.[16a]
The two limonene enan-
tiomers known to occur in
nature are produced as
either a single enantiomer
or as a mixture of enantio-
mers, depending on the spe-
cies. Limonene is derived
from GPP, and through cell-
free extracts and enzyme
preparations two distinct
limonene cyclases (syn-
thases) have been identified
from several spe-
cies.[4,15d,17–24] As shown in
Scheme 2, treatment of tri-
tium-labeled GPPwith limo-
nene synthase isolated from
Mentha piperita (pepper-
mint) and Mentha spicata
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Table 1: Occurrence and biological activity of enantiomeric monoterpenes.
Monoterpene Species Biological activity
Mentha piperita (peppermint),[17] Mentha spicata (spearmint),[17] Mentha pulegium (Euro-
pean pennyroyal),[17] Perilla frutescens (Chinese basil),[18, 19] Perilla citriodora,[26] Abies grandis
(grand fir),[20] Anethum graveolens L. (dill),[27] Semiardistomis puncticollis (carabid beetle),[28]
Mentha cardiaca (Scotch spearmint),[21] Salvia officinalis (sage),[18] Pinus sylvestris (Scots
pine),[29] pine needle oil,[9] Oleum cinae,[9] Pistacia vera L. (pistachio),[30] Angelica arch-




(+)-(4R)-limonene Mentha piperita,[17] Mentha spicata,[17] Schizonepeta tenuifolia (Japanese catnip),[22] Citrus
unshiu (mandarin orange),[21] Anethum graveolens L.,[27] Carum carvi L. (caraway fruit),[23]
Ardistomis schaumii (carabid beetle),[28] Mentha cardiaca,[21] Salvia officinalis,[18] Pinus
sylvestris,[29] Citrus limon (lemon),[24] Citrus sinensis (Valencia orange),[18] oil of orange rind,[9]
dill oil,[9] oil of cumin, neroli, bergamot caraway and lemon (Citrus, Antethum, Juniperus,
Peucedanum spp.),[9] Oleum cinae,[9] Pistacia vera L.,[30] Angelica archangelica L.[31]
orange odor[16b]
shows insecticidal properties[9]
Mentha spicata,[32] Mentha cardiaca,[21] Tanacetum balsamita (balsam herb)[16] spearmint odor[16a]
()-(4R)-carvone
(+)-(4S)-carvone Anethum graveolens L.,[27] Carum carvi L.[23] caraway odor[16a]
Abies grandis,[20] Pinus contorta (lodgepole pine),[33] Pinus taeda (loblolly pine),[34] Salvia




(+)-a-pinene Pinus contorta,[33] Pinus taeda,[34] Salvia officinalis,[18, 35] Pinus sylvestris,[29] Pistacia vera L.,[30]
Angelica archangelica L.,[31] Eucalyptus spp.[9]
pine odor[16a]
Abies grandis,[20] Pinus contorta,[33] Pinus taeda,[34] Salvia officinalis,[18, 35] Pinus sylvestris,[29] Citrus
limon,[24] Pistacia vera L.,[30] Angelica archangelica L.[31]
()-b-pinene
(+)-b-pinene Pinus contorta,[33] Pistacia vera L.,[30] Angelica archangelica L.[31]
Pinus contorta[36]
()-a-phellandrene
(+)-a-phellandrene Anethum graveolens L.[27]
Pinus contorta,[36] Pinus sylvestris,[29] Angelica archangelica L.,[31] Juniperus spp. (Juniper
evergreen),[9] Pinus spp. (pine)[9]
()-b-phellandrene
(+)-b-phellandrene Anethum graveolens L.,[27] Angelica archangelica L.,[31] Bupleurum fruticosum (Shrubby Hare’s
Ear),[9] Juniperus spp.[9]
Salvia officinalis,[37] Picea abies,[29] Pinus sylvestris,[29] Angelica archangelica L.[31]
()-camphene
(+)-camphene Salvia officinalis,[37] Picea abies,[29] Pinus sylvestris,[29] Angelica archangelica L.[31]
Picea pungens glauca (Colorado blue spruce),[38] Salvia officinalis,[38] Picea mariana nana
(dwarf black spruce),[38] Thuja occidentalis (Northern Whitecedar),[38] Pinus sylvestris,[38]
Tanacetum vulgare L. (tansy),[39] Chrysanthemum parthenium L. (feverfew),[40] Artemisia
cana L. (silver sagebrush),[40] Chrysanthemum balsamita L. (costmary),[40] Matricaria par-
thenium (wild camomile),[9] Chrysanthemum sinense (mum),[9] Chrysanthemum indicum
(mum)[9]
camphoraceous odor[16a]()-camphor
(+)-camphor Picea mariana nana,[38] Picea albertiana conica (dwarf white spruce),[38] Picea sitchensis (Sitka
spruce),[38] Artemesia californica (coastal sagebrush),[38] Chamaecyparis lawsoniana (Law-
son’s cypress),[38] Pinus sylvestris,[38] Salvia officinalis,[38] Salvia leucophylla L. (San Luis purple
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[3H]limonene.[17] On the other hand, a soluble limonene
cyclase preparation was obtained from Citrus sinensis (Valen-
cia oranges), which when treated with tritium-labeled GPP
afforded enantiomerically pure (+)-limonene.[18] Likewise,
when tritium-labeled GPP was treated with a limonene
synthase isolated from Carum carvi L. (caraway seeds),
a 98:2 mixture of (+)- and ()-limonene was observed, thus
indicating that the limonene synthase from caraway seeds
favors formation of (+)-limonene.[24]
Carvone is also a cyclic monoterpene, of which both
enantiomers have been isolated. Through precursor incorpo-
ration studies and enzyme preparations, limonene has been
established as a biosynthetic precursor to carvone.[17a,23,25] Two
sets of enantioselective enzymes responsible for the conver-
sion of (+)- or ()-limonene into (+)- or ()-carvone,
respectively, have been isolated and characterized. As shown
in Scheme 3, ()-limonene-6-hydroxylase and ()-trans-car-
veol dehydrogenase have been identified in Mentha spicata
(spearmint) which catalyze the enantioselective conversion of
()-limonene into ()-trans-carveol and finally into ()-
carvone.[25] While these enzymes are highly stereospecific, the
corresponding enantiomeric enzymes found in Carum
carvi L. were not completely stereo- or substrate-specific.
Both (+)- and ()-limonene served as substrates for
(+)-limonene-6-hydroxylase, and when (+)-limonene was
treated with the enzyme, only 97% of the expected (+)-trans-
carveol was isolated. The other 3% was made up of a mixture
of ()-trans-carveol and ()-cis-carveol. Finally, carveol
dehydrogenase displays moderate substrate specificity, as
evident by the conversion of not only (+)-trans-carveol into
(+)-carvone, but also ()-cis-carveol into ()-carvone.[23]
Table 1: (Continued)
Monoterpene Species Biological activity
Thuja orientalis (Chinese Arborvitae),[38] Thuja standishii (Japanese Thuja),[38] Pinus
sylvestris[29]
camphoraceous odor with woody
undertones[16b]
()-borneol
(+)-borneol Picea sitchensis,[38] Chamaecyparis lawsoniana,[38] Pinus sylvestris,[29] Salvia officinalis[38] camphoraceous odor with earthy-
peppery undertones[16b]
Pinus sylvestris,[29] Angelica archangelica L.[31]
()-sabinene
(+)-sabinene Pinus sylvestris,[29] Salvia officinalis,[41] Angelica archangelica L.[31]
Scheme 2. Enantioselective biogenesis of limonene.




4807Angew. Chem. Int. Ed. 2012, 51, 4802 – 4836  2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
2.1.2. Pinene
a-Pinene and b-pinene are widely distributed bicyclic
monoterpenes and serve as the major constituents in the
volatile oil from Salvia officinalis (common sage).[18,35] Both
enantiomers of a-pinene are natural products and can co-
occur with either enantiomer predominating. In contrast, b-
pinene is almost always isolated as the optically pure () iso-
form. The (+)-b-pinene isomer is also known, although the
production of this metabolite is rare.[30,31,33] Biosynthetic
studies carried out by Gambliel and Croteau in the 1980s
revealed that the two enantiomeric pinene cyclases
(+)-pinene cyclase (cyclase I) and ()-pinene cyclase (cycla-
se II) exist within Salvia officinalis.[42] Croteau and co-workers
demonstrated that when [3H]GPP was treated with each
individual cyclase, the corresponding a-pinene enantiomers
were formed (Scheme 4). In addition, ()-b-pinene was
formed from the reaction with cyclase II, whereas (+)-b-
pinene was not detected from either cyclase reaction. Minor
amounts of (+)- and ()-camphene and limonene were also
formed as scalemic mixtures from these reactions (80%
(+)-camphene isomer and 55% ()-limonene isomer).[35,42,43]
2.2. Sesquiterpenes
The sesquiterpenes make up a diverse group of acyclic and
cyclic C15 terpenes that are isolated from a wide variety of
plant, fungal, bacterial, marine, and insect species. Similar to
the monoterpenes, sesquiterpenes are often found as compo-
nents of essential oils, such as vetiver oil and cubeb oil, and
display a wide range of pharmacological activities.[44,45]
Unfortunately, in most cases, the optical rotation of the
sesquiterpenes is not reported, and thus critical information
regarding their biological activity remains unknown.
Over the past two decades numerous sesquiterpene
synthases have been isolated and characterized, including 5-
epiaristolochene,[46] epiubenol,[47] pentalene,[48] germacre-
ne C,[49] g-humulene,[49] and d-selinene,[50] and the mechanisms
of these enzymes have also been investigated;[11,45,51] however,
the biosynthetic formation of enantiomeric sesquiterpenes
has, for the most part, remained obscure. Recently, Kçnig and
co-workers isolated and characterized two enantioselective
germacrene D synthases from Solidago canadensis.[44,45] The
presence of these two cyclases within S. canadensis helps to
explain the production of both enantiomers of germacrene D
within the species, as well as support the possibility that the
biosynthetic pathway of other enantiomeric sesquiterpenes
arises from multiple enantioselective enzymes within differ-
ent species of the same genera.
Most sesquiterpenes are chiral, and some members of this
family of natural products have been found to be produced in
both enantiomeric forms.[44] In general, enantiomeric sesqui-
terpenes are produced by different species within the same
genera (Table 2); however, there are notable exceptions, such
as the isolation of both enantiomers of germacrene D from
Solidago canadensis and S. altissima.[45,52] Another unique
example is the isolation of both enantiomers of furody-
sinin from Dysidea herbaceae. The (+) isoform is isolated
from D. herbaceae collected from Australia,[53] whereas
the () isoform is produced by the same species collected
in Fiji.[54] Another observable trend in the isolation of
enantiomeric sesquiterpenes is that terrestrial and marine
sources have sometimes been observed to produce
opposite enantiomers. An example of this is seen in the
isolation of several sesquiterpenes from the soft coral
Sinularia mayi. Seven of the major metabolites isolated
from S. mayi were the opposite enantiomers of the more
common forms found in terrestrial sources.[55] This is most
likely a common occurrence; however, the stereochemical
investigation of marine sesquiterpenoids is frequently
disregarded.[56]
2.3. Diterpenes
Diterpenes are isolated from numerous plants and
fungi, and are generally found in resins and essential oils. The
structurally diverse family of diterpenes contains a C20
skeleton and is derived from the condensation of three
equivalents of isopentenyl pyrophosphate (IPP) with dime-
thylallyl pyrophosphate (DMAPP) to afford the acyclic
geranylgeranyl diphosphate (GGPP) precursor.[10]
Similar to the monoterpenes and sesquiterpenes, enan-
tiomeric diterpenes have been isolated, although their
occurrence is rather rare (Table 3). The production of both
enantiomers of various diterpenes can occur within the same
species or—more commonly—within different species of the
same genera. Unfortunately, biosynthetic studies on the
formation of enantiomeric diterpenes have not been reported.
Additionally, no biological activity has been reported for any
of the individual diterpene enantiomers. As observed with the
sesquiterpenes, optical rotation is generally not reported upon
isolation of the diterpenes and, therefore, information con-
cerning the occurrence and biological activity of enantiomeric
diterpenes is lacking.
Scheme 4. Enantioselective pinene cyclases.
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Table 2: Enantiomeric sesquiterpenes.
Sesquiterpene Species Biological activity
Ceroplastes rubens (scale insect),[57] Dendropanax trifidusM. (ivy tree),[58] Sinularia mayi (soft coral),[55]
Preissia quadrata (liverwort),[59] Solidago altissima (late goldenrod),[52] Solidago canadensis (Canada
goldenrod),[60] Podocarpus spicatus (black pine),[61] Zingiber officinale (ginger)[60]
(+)-germacrene D
()-germacrene D Ceroplastes ceriferus (scale insect),[57] Solidago altissima,[52] Solidago canadensis,[60] Pogostemon cablin
(patchouli),[60,62] Pseudotsuga japonica (Japanese Douglas fir),[9] Araucaria bidwillii (bunya pine),[63]
Vitis vinifera (common grape vine),[60] Populus trichocarpa x deltoides (California poplar)[60]
Araucaria bidwillii,[63] Carum carvi L.,[64] Gossypium arboreum (tree cotton),[60] Gossypium hirsutum
(upland cotton),[60] Mentha piperata[9]
(+)-d-cadinene
()-d-cadinene Ceroplastes ceriferus,[57] Sinularia mayi,[55] Araucaria araucana (monkey-puzzle tree),[63] Araucaria
bidwillii,[63] Carum carvi L. ,[64] Heteroscyphus planus[65]
Streptomyces sp. LL-B7 (bacteria),[66] Heteroscyphus planus,[65] Scapania undulata (liverwort),[64]
Juniperus rigida (temple juniper),[67] Streptomyces sp. B-7 (bacteria)[68]
(+)-epicubenol
()-epicubenol Cubeb oil,[69] Juniperus rigida,[67] Cedrus atlantica (Atlas cedar)[9]
Leptospermum scoparium (tea tree)[70]
(+)-d-amorphene
()-d-amorphene Vetiveria zizanioides (L. Nash ex Small) (vetiver oil)[71]
Conocephalum conicum (scented liverwort)[70]
(+)-cadina-3,5-diene
()-cadina-3,5-diene Leptospermum scoparium,[70] Piper cubeba oil[70]





Leptospermum scoparium,[70] Piper cubeba (tailed pepper)[70]
Dysidea sp. (marine sponge),[72] Dysidea herbaceae (marine sponge, Australia)[53]
(+)-furodysinin
()-furodysinin Dysidea herbaceae (marine sponge, Fiji),[54] Dysidea tupha,[73] Ceratosoma trilobatum (sea slug)[74] feeding deterent,[74]
ichthyotoxic[74]
Disidea pallescens (Black Sea sponge)[75]
(+)-chromazonarol
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3. Phenylpropanoids
Phenylpropanoids are found in numerous plant species
and contribute greatly to plant defenses, structure, pigments,
and reproduction.[85] Derived from the shikimate pathway, the
phenylpropanoids are a class of natural products comprised of
a vast array of diverse secondary metabolites formed from l-
phenylalanine and/or l-tyrosine.[3] Lignins, lignans, flavo-
noids, coumarins, quinones, stilbenes, catechin, aurones, and
neoflavonoids are just a few of the many different types of
phenylpropanoids derived from the enzymatic conversion of
phenylalanine into the key intermediate p-coumaroyl-CoA
by way of the general phenylpropanoid pathway.[86]
3.1. Lignans
Lignans are phenylpropanoid dimers linked by the central
C8 carbon atoms of two phenylpropane units and make up an
abundant class of phenylpropanoids.[87,88] Lignans are isolated
from a wide range of plant species, specifically trees, and are
believed to help prevent heart rot in trees.[88] They also display
a plethora of biological activities, such as antitumor, anti-
mitotic, and antiviral properties.[89] Some of the lignans
produced early in the biosynthetic pathway also serve as
lead compounds in the development of new drugs for use in
cancer therapies, such as the well-known podophyllotoxin-
derived semisynthetic drug etoposide.[89,90]
Lignans can occur as mixtures of enantiomers with various
enantiomeric compositions, depending on the specific plant
species. One extensively examined type of lignan is the early
9(9’)-oxygenated lignans (pinoresinol, lariciresinol, secoiso-
lariciresinol, and matairesinol). These lignans exists as either
enantiomerically pure compounds or as enantiomeric mix-
tures with various enantiomeric constitutions.[91] As shown in
Table 4, several trends are noticeable with these naturally
occurring lignans: furofuran and furan lignans have never
been isolated in optically pure form, while all the dibenzyl-
butyrolactone lignans analyzed by HPLC on a chiral sta-
tionary phase have been found to be optically pure. Fur-
thermore, the predominant enantiomer of furofuran, furan,
and dibenzylbutane lignans vary with the plant species.[91] The
Table 2: (Continued)
Sesquiterpene Species Biological activity
Dictyopteris zonarioides (brown seaweed),[64,78] Conocephalum conicum[70]
(+)-zonarene












()-pallescensin A Doriopsilla areolata (sea slug)[80]
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optical rotation of the enantiomerically pure dibenzylbutyro-
lactone lignans were also found to vary between plant
species.[92]
Like all phenylpropanoids, the lignans are derived
through the cinnamate pathway. The biosynthetic pathway
of 9(9’)-oxygenated lignans is one of the most well-studied
lignan pathways. The first five steps of this pathway have been
investigated extensively and most of the enzymes responsible
for the transformations and enantiomeric diversity seen in
these types of lignans have been isolated and characterized.
To date, several enantioselective lignan-producing enzymes
have been isolated and characterized. As shown in Scheme 5,
the 9(9’)-oxygenated lignans are formed by the enantioselec-
tive dimerization of two coniferyl alcohol residues by an
oxidase in the presence of a dirigent protein to afford
pinoresinol in an enantiomeric excess. The dirigent protein
aids in controlling the stereospecificity of the bimolecular
phenoxy radical coupling reactions of the two coniferyl
alcohol units.[93] Next, pinoresinol is stereoselectively reduced
to lariciresinol, which is subsequently reduced stereospecifi-
cally to secoisolariciresinol by pinoresinol/lariciresinol reduc-
tase. Two isoforms of this enzyme have been isolated, each
displaying opposite enantioselectivity (Scheme 6).
(+)-Pinoresinol/(+)-lariciresinol reductase has been iso-
lated from Forsythia intermedia and Thuja plicata, whereas
the ()-pinoresinol/()-lariciresinol reductase was isolated
from Thuja plicata.[94,95] It was determined through incorpo-
ration studies that (+)-pinoresinol/lariciresinol reductases
Table 3: Diterpenes.
Diterpene Species













()-16-kaurene Dacrydium intermedium T. Kirk,[82] Araucaria
bidwillii,[63] Araucaria araucana,[63] Araucaria
heterophylla[63]
Dacrydium intermedium,[82] Araucaria bidwil-
lii,[63] Araucaria heterophylla[63]
(+)-sclarene
()-sclarene Podocarpus spicatus,[61] Dacrydium interme-
dium,[82] Araucaria araucana,[63] Araucaria
heterophylla[63]
Scheme 5. Enantioselective biosynthesis of (+)-pinoresinol.
Scheme 6. Enantioselective conversion of pinoresinol into secoiso-
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Table 4: Enantiomeric lignans.
Lignans Species Biological activity
Forsythia koreana (Korean flowering plant, 82% ee),[91] Linum flavum var. compactum
(dwarf golden flax, 65% ee),[91] Larix leptolepis (Japanese larch, 92% ee),[91,92]
Wikstroemia viridiflora,[92] Stellera chamaejasme (Tibetan flowers),[92] Forsythia suspensa




()-pinoresinol Wikstroemia sikokiana (deciduous shrub, 74% ee),[91] Daphne odora (winter Daphne,
95% ee),[91] Daphne genkwa (92% ee),[91] Daphne tangutica,[92] Zanthoxylum ailanthoides
(Japanese prickly ash),[92] Zanthoxylum kellermanii,[92] Senecio scandens (wild daisy)[99]
antioxidant[99]
Wikstroemia elliptica,[92] Daphne tangutica,[92] Passerina vulgaris,[92] Dirca occidentalis
(western leatherwood)[93]
(+)-syringaresinol
()-syringaresinol Daphne tangutica,[92] Zanthoxylum acanthopodium,[92] Daphne genkwa[100] anticancer[100]
Zanthoxylum acanthapodium,[92] Zanthoxylum valens,[92] Zanthoxylum setulosum[92] antihypertensive[101]
(+)-sesamin
()-sesamin Zanthoxylum piperitum (Japanese pepper tree)[92]
Forsythia koreana (35% ee),[91] Linum flavum var. compactum (70% ee),[91] Wikstroemia




()-lariciresinol Wikstroemia sikokiana (39% ee),[92] Daphne odora (89% ee),[92] Daphne genkwa
(88% ee),[92] Wikstroemia elliptica,[93] Daphne tangutica,[93] Dirca occidentalis[93]
phytotoxic (inhibits root growth
of Italian ryegrass)[102]
Arctium lappa (burdock, petiole) (81% ee),[91] Phyllanthus sp. (98% ee),[91] Daphne
odora (>99% ee),[91] Daphne genkwa (97% ee)[91]
antioxidant[103]
(+)-secoisolariciresinol
()-secoisolariciresinol Arctium lappa (seeds) (65% ee),[91] Forsythia koreana (>99% ee),[91] Forsythia inter-
media (>99% ee),[91] Wikstroemia sikokiana (45% ee),[91] Zanthoxylum ailanthoides,[92]
Larix leptolepis,[92] Larix decidua (European larch),[92] Araucaria angustifolia,[92] Podocar-
pus spicatus[92]
antioxidant[103]
Wikstroemia indica,[92] Daphne genkwa[100] anticancer[100]
(+)-arctigenin
()-arctigenin Arctium lappa (seeds) (>99% ee),[91] Forsythia koreana (>99% ee),[91] Forsythia
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converts (+)-pinoresinol into ()-secoisolariciresinol, and the
opposite reductase converts ()-pinoresinol into (+)-secoi-
solariciresinol.[95]
The final enzymatic conversion of secoisolariciresinol into
enantiomerically pure matairesinol is not yet fully under-
stood. ()-Matairesinol is formed biosynthetically in various
plant species (i.e. Forsythia intermedia, Arctium lappa, Thuja
occidentalis); however, the optically pure dextrorotatory
enantiomer of matairesinol is produced in Thymelaeaceae
plants (Wikstroemia sikokiana and Daphne odora). Secoiso-
lariciresinol dehydrogenase was isolated from Forsythia
intermedia and found to catalyze the enantioselective con-
version of ()-secoisolariciresinol into ()-matairesinol
(Scheme 7).[96] Secoisolariciresinol dehydrogenase prepara-
tion was also obtained from Daphne odora and Daphne
genkwa, both known producers of the (+) enantiomer of
matairesinol; however, the in vitro reactions with enzyme
preparation of both Daphne species resulted in the prefer-
ential formation of ()-matairesinol.[97] To date, the biosyn-
thesis of (+)-matairesinol remains unknown.
Table 4: (Continued)
Lignans Species Biological activity
Wikstroemia sikokiana (>99% ee),[91] Daphne odora (>99% ee),[91] Daphne genkwa
(>99% ee),[91] Centaurea pamphylica[104]
(+)-matairesinol
()-matairesinol Arctium lappa (seeds) (>99% ee),[91] Forsythia koreana (>99% ee),[91] Forsythia
intermedia (>99% ee),[91] Stellera chamaejasme,[92] Forsythia spp.,[92] Trachelospermum
asiaticum var. intermedium,[92] Zanthoxylum kellermanii,[92] Picea excelsa (Norway
spruce),[92] Tsuga mertensiana (mountain hemlock),[92] Thuja occidentalis (>99% ee)[91]
antioxidant[104]
Wikstroemia viridiflora,[92] Wikstroemia foetida,[92] Wikstroemia sikokiana (>99% ee),[91]
Wikstroemia indica,[92] Daphne odora,[92] Passerina vulgaris[92]
anticancer[106]
(+)-wikstromol
()-wikstromol Thuja occidentalis (>99% ee),[91] Trachelospermum asiaticum var. intermedium,[92]
Trachelospermum axillare[92]
anticancer[107]
Leucas aspera (common Leucas),[108] Machilus thunbergii (Japanese bay tree)[109] neuroprotective[109]
(+)-licarin A
()-licarin A Leucas aspera[108]
Schisandra sp.[110]
(+)-chicanine
()-chicanine Leucas aspera[108] antioxidant[108b]
Scheme 7. ()-Matairesinol biosynthesis by secoisolariciresinol dehy-
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3.2. Flavonoids
Flavonoids make up a large, diverse family of aromatic
secondary metabolites that are largely characterized by the
red, blue, and purple pigments found in plants.[111] As
a consequence of their colorful pigmentation, flavonoids are
believed to act as an aid in plant reproduction by recruiting
pollinators and seed dispersers. More recently, flavonoids
have become an area of interest because of their association
with the health benefits of wine, chocolate, fruits, and
vegetables.
As shown in Table 5, the enantiomeric flavonoids occur
mostly within three structural groups of flavonoids: the
flavanones, flavonols, and isoflavonoids. Elucidation of the
flavonoid biosynthetic pathway has been an area of growing
research, with much of the attention recently being directed at
the molecular genetics of the pathway.[71,86,111] Many of the
enzymes responsible for the biosynthesis of the different
subgroups of flavonoids have been isolated and character-
ized; however, the biosynthesis of enantiomeric flavonoids
remains largely unresolved.
The biosynthesis of enantiomeric medicarpin has been
investigated in both Medicago sativa L. (alfalfa) and Arachis
hypogea (peanut), which are known producers of ()- and
(+)-medicarpin, respectively. The complete biosynthetic
pathway of ()-medicarpin has been determined by bio-
Table 5: Enantiomeric flavonoids.
Flavonoid Species Biological activity









Dalbergia decipularis Rizz. et Matt. (tulipwood),[114] Dalbergia riparia,[114] Dalbergia variabilis,[114]





()-medicarpin Dalbergia stevensonii,[114] Trigonella foenum-graecum (Fenugreek),[115] Medicago sativa (alfalfa)[118] antimicrobial[115]
phytoalexin[115]
Acacia mearnsii (black wattle),[119] Acacia decurrens (green wattle),[119] Acacia dealbata (silver wattle),[119]
Acacia pycnantha (golden wattle),[119] Chamaerops humilis (Mediterranean dwarf palm),[109] Phoenix
canariensis (Canary Island date palm),[120] Butia capitata (jelly palm),[120] Howea forsteriana (thatch
palm)[120]
(+)-catechin
()-catechin Chamaebatia foliolosa Benth (mountain misery),[121] chocolate[122]
Chamaerops humilis,[120] Livistona chinensis (fountain palm)[120]
(+)-epicatechin
()-epicatechin Acacia dealbata,[119] Acacia pycnantha[119]
Arachis hypogaea (peanut hulls),[123] Hemizonia increscens (grassland tarweed)[123]
(+)-eriodictyol
()-eriodictyol Arachis hypogaea,[123] Hemizonia increscens,[123] Thymus vulgaris[123]
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chemical techniques and confirmed by gene cloning and
expression experiments.[112,113] As shown in Scheme 8, the
advanced achiral precursor 2’-hydroxyformononetin is con-
verted into (R)-vestitone by isoflavone reductase, which
subsequently reacts with pterocarpan synthase to yield ()-
medicarpin in alfalfa.[112] In contrast to what is known
regarding the biosynthesis of ()-medicarpin, there are
several unanswered questions concerning the biosynthesis of
(+)-medicarpin in peanuts. Surprisingly, the isoflavone reduc-
tase in peanuts produces the same (R)-vestitone intermediate
generated in alfalfa. This compound has the opposite
substrate and product stereospecificity necessary for the
pterocarpan synthase, thus indicating the possibility of an
epimerase in peanuts.
3.3. Coumarins
Coumarins are generally produced by higher plants and
are also derived from the general phenylpropanoid pathway.
Coumarins play an important role for plants by acting as
a defense against phytopathogens.[124] They also display
myriad bioactivities for human therapeutics, including anti-
biotics, anticoagulants, and analgesic properties.[125] Unlike
the lignans and flavonoids, the formation of enantiomeric
coumarins is not as common (Table 6), and therefore the
biosynthesis of these enantiomeric secondary metabolites has
not been investigated.
3.4. Neoflavonoids
The neoflavonoids are a group of secondary metabolites
containing a C6-C3-C6 skeleton and are closely related both
structurally and biogenetically to the flavonoids, isoflavo-
noids, coumarins, and quinones.[3,126] The neoflavonoids are
found in a wide variety of plant families, including the
Scheme 8. Biosynthesis of the medicarpin enantiomers.[112]
Table 6: Enantiomeric coumarins.
Coumarins Species Biological activity
Angelica gigas (aerial),[128] Angelica gigas Nakai (roots)[129]
anticancer,[130] antihelicobacterpyloric,[131] anti-





Angelica gigas (aerial),[128] Aegle marmelos,[134] Ferulago campestris
(aegelinol benzolate),[135] Eryngium campestre (benzoyl aegeli-
nol)[136]
antibacterial[135]
Angelica gigas (roots),[137] Angelica gigas (aerial),[128] Angelica sinensis






Ferulago campestris,[135] Eryngium campestre[136]




(R)-agasyllin Angelica gigas (aerial),[128] Ferulago campestris,[135] Eryngium cam-
pestre[136]
antibacterial,[135] antihelicobacterpyloric[135]
Peucedanum praeruptorum Dunn.[139] reduces blood pressure[139]
(+)-praeruptorin A
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Guttiferae, the Leguminosae, the Rubiaceae, the Passiflor-
aceae, the Polypodiaceae, and the Compositae families.
4-Methoxydalbergione is an open-chained neoflavonoid
that contains a stereogenic center at the C7-position, and is
naturally produced as the (R) or (S) isoform from various
species of the genera Dalbergia.[127] As shown in Table 7, the
occurrence of enantiomeric open-chain neoflavonoids in
nature is limited, and the biogenesis of enantiomeric neo-
flavonoids is thus unknown.
3.5. Quinones
Through numerous feeding experiments, it has been
determined that quinones are also derived from phenyl-
alanine, which is converted into the known intermediate p-
hydroxybenzoic acid (PHB).[151] Subsequent prenylation at
the C3-position affords m-geranyl-p-hydroxybenzoic acid,
which is further converted into a key intermediate (geranyl-
hydroquinone) in the biosynthesis of enantiomeric shikonin
and alkannin (Scheme 9). Currently, the early steps in the
biosynthesis of shikonin and alkannin are far more under-
stood than the later steps. As shown in Table 8, these
enantiomeric quinones and their derivatives display a plethora
of biological activities, including anti-inflammatory, antitu-
mor, and antimicrobial activity. A more in depth review of the
chemistry and biology of alkannin, shikonin, and their
quinone derivatives can be found in the review by Nicolaou
and co-workers.[151]
4. Polyketides
Derived from acetate, polyketides represent a structurally
diverse family of secondary metabolites produced by a wide
variety of plants, fungi, bacteria, and insects.[3,154] The exact
role of polyketides in producing organisms is not known;
however, it appears as though several serve as either chemical
defense agents or aid in the growth and development of
plants. Polyketides also display important medicinal activity,
such as antibiotic, anticancer, and immunosuppressant prop-
erties.
There are several examples of enantiomeric polyketides
biosynthesized in the plant kingdom (Table 9); however, little
is known about the enantioselective biosynthesis of many of
these secondary metabolites. To date, extensive research has
been carried out at an enzymatic level on the enantiomeric
formation of macrotetrolide antibiotics (nactins) and benzyl-
isochromanequinone antibiotics.
4.1. Macrotetrolides
The macrotetrolide antibiotics (nactins) are mainly pro-
duced by Streptomyces species and are biosynthetically
formed from four monomeric units of nonactic acid (NA) or
its homologues, homononactic acid and/or bishomonanactic
acid (Figure 2).[155,156] Of the five known homologues (non-
actin, monactic, dinactin, trinactin, and tetranactin), biosyn-
thetic studies mostly focus on nonactin, a 32-membered
macrocycle composed of two alternating units of (+)-nonactic
acid and ()-nonactic acid, which in turn makes nonactin
achiral.[155,156,173–175]
The biosynthesis of nonactin has been highly studied
through in vivo feeding esperiments with 13C-, 2H-, and 18O-
labeled precursors,[173] and by the isolation of both nonactic
acid enantiomers and its dimer.[156] Recently, the biosynthetic
research on nonactin has centered around the isolation and
characterization of the genes and enzymes responsible for the
biosynthesis of both enantiomers of nonactic acid.[155i] The
biosynthesis of both NA enantiomers resulted in the proposal
that the enantiomeric polyketide intermediates arise from
Table 7: Neoflavonoid enantiomers.
Neoflavonoid Species Biological activity
Dalbergia violacea,[127] Dalbergia baroni Baker (Madagascar rosewood),[140] Dalbergia cultrate (Khamphi
rosewood),[141] Dalbergia melanoxylon (African blackwood),[142] Dalbergia inundata,[143] Dalbergia
nitidula,[144] Dalbergia miscolobium[145]
(S)-methoxydalbergione
(R)-methoxydalbergione Dalbergia niger Fr. Allem. (Bahia rosewood),[127] Dalbergia latifolia Roxb. (Indian rosewood),[127c, 146]
Dalbergia parviflora,[147] Dalbergia cochinchinensis (Thiland rosewood),[148] Dalbergia retusa (Coco-
bolo)[149]
antiplasmodial[150]
Scheme 9. Proposed biosynthesis of shikonin and alkannin.
.Angewandte
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Table 8: Natural quinone enantiomers.[a]
Quinone Species Biological activity
Alkanna tinctoria (Alkanet), Arnebia hispidissima, Arnebia
nobilis, Arnebia tinctoria, Macrotomia cephalotes, Macro-
tomia euchroma (Syrian Alkanet), Onosma echioides,
Onosma paniculata, Plagiobotrys arizonicus





Arnebia euchroma, Arnebia hispidissima, Arnebia guttata,
Arnebia tibetiana, Cynoglossum officinale (Gypsyflower),
Echium lycopsis, Echium rubrum, Echium vulgare (blue-
weed), Eritrichium incanum, Eritrichium sichotenze, Jatropha
glandulifera, Lappula consanguinea, Lappula echinata (blue-
bur), Lithospermum erythrorhizon (purple Gromwell), Lith-
ospermum officinale (European stoneseed), Macrotomia
echioides, Macrotomia ugamensis, Macrotomia euchroma,
Mertensia maritima (sea lungwort), Onosma caucasicum,
Onosma conferitum, Onosma hookeri, Onosma livanovii,
Onosma polyphyllum, Onosma tauricum, Onosma sericium,
Onosma setosum, Onosma visianii, Onosma zerizaminium
antitumor, antiamebic, antipyretic and analgesic, antifun-
gal, antibacterial, wound healing, chemopreventive, anti-
inflammatory, inhibition of topoisomerase-II, inhibition of
microsomal monooxygenase, stimulation of peroxidase,
protection from UV radiation, inhibition of testosterone-a-
reductase, induction and secretion of nerve growth factors
Alkanna tinctoria, Arnebia euchroma, Arnebia hispidissima,
Arnebia nobilis, Macrotomia cephalotes
antimicrobial, inhibition of topoisomerase-I, antithrom-
botic, antitumor
acetylalkannin
acetylshikonin Arnebia decumbens, Arnebia euchroma, Arnebia guttata,
Cynglossum officinale, Echium vulgare, Eritrichium incanum,
Eritrichium sichotenze, Jatropha glandulifera, Lappula con-
sanguinea, Lappul echinata, Lithospermum arvense (field
Gromwell), Lithospermum erythrorhizon, Mertensia mari-




isobutyrylshikonin Cynoglossum officinale, Echium vulgare, Eritrichium sicho-
tenze, Lappula consanguinea, Lappula echinata, Lithosper-
mum arvense, Lithospermum erythrorhizon, Macrotomia
euchroma, Mertensia maritima
Alkanna tinctoria, Arnebia hispidissima, Arnebia tinctoria,
Macrotomia cephalotes, Onosma heterophylla
inhibition of topoisomerase-I
isovalerylalkannin
isovalerylshikonin Arnebia decumbens, Cynoglossum officinale, Echium vulgare,
Lappula consanguinea, Lappula echinata, Lithospermum
arvense, Lithospermum erythrorhizon, Macrotomia euchroma
Alkanna tinctoria, Macrotomia cephalotes antimicrobial
a-methylbutyrylalkannin
a-methylbutyrylshikonin Cynoglossum officinale, Echium vulgare, Eritrichium incanum,
Eritrichium sichotenze, Lappula consanguinea, Lappula echi-
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Table 8: (Continued)
Quinone Species Biological activity
Alkanna tinctoria, Arnebia euchroma, Arnebia gutatta, Arne-
bia nobilis, Lithospermum erythrorhizon, Macrotomia cepha-
lotes, Onosma heterophylla, Onosma hookeri, Onosma
paniculata
inhibition of topoisomerase-I and anticancer, antimicro-
bial, antithrombotic, anti-inflammatory
b,b-dimethylacrylalkannin
b,b-dimethylacrylshikonin Alkanna hirsutissima, Arnebia euchroma, Arnebia guttata,
Arnebia tibetiana, Cynoglossum officinale, Echium vulgare,
Eritrichium incanum, Eritrichium sichotenze, Jatropha glan-
dulifera, Lappula consanguinea, Lappula echinata,
Echium spp., Lithospermum erythrorhizon, Macrotomia
ugamensis, Mertensia maritima, Moltkiopsis ciliata, Onosma














b-hydroxyisovalerylshikonin Arnebia euchroma, Arnebia guttata, Lithospermum arvense,
Lithospermum erythrorhizon, Lithospermum euchromum
antimicrobial





Streptocarpus dunnii (Cape Primrose),[152] Calceolaria integ-
rifolia[153]
(+)-dunnione
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a pair of enantiospecific pathways. The proposed biogenesis
of the macrotetrolides is supported through both feeding and
enzymatic studies, which were carried out individually by the
research groups of Robinson, Priestley, and Shen.[155i, 173–175] As
shown in Scheme 10, the nactins are derived from malonyl-
CoA, succinyl-CoA, and acetyl-CoA, which results in the
formation of proposed intermediate 1. Biosynthetic studies
performed by Robinson and co-workers using 14C-labeled
compounds established that propionate also serves as a pri-
mary metabolic precursor, which most likely results in the
formation of the proposed achiral intermediate 2.[173] Since 2
is achiral, it can serve as a common precursor to both
enantiocomplementary pathways of nonactic acid.
Opposite stereospecific reductions of 2 would result in the
generation of enantiomeric precursors 3 and 4. Studies carried
out by Robinson and Spavold confirmed that the acyclic
intermediates 3 and 4, as well as (6R,8R)- and (6S, 8S)-2-
methyl-6,8-dihydroxynon-(2E)-enoic acids (NEA), were
incorporated enantioselectively into nonactin via the respec-
tive (+)- and ()-nonactate precursors.[173b] However, the
details of the conversion of the primary metabolites into 3 and
4 are still relatively unknown. Shen and co-workers garnered
additional support for enantioelective pathways through
enzymatic studies with NonS.[155i] They demonstrated that
nonS governs only the enantioselective formation of ()-NA
and its homologues in S. griseus ; however, the enzyme
responsible for the biosynthesis of (+)-NA remains elusive.
4.2. Benzoisochromanequinones
Kalafungin, actinorhodin, medermycin, dihydrogranati-
cin, and nanaomycin are all antifungal and antimycoplasmal
antibiotics that possess a benzoisochromanequinone (BIQ)
skeleton and are produced by various Streptomyces spe-
cies.[176] Structurally, the BIQs all show a trans configuration in
respect of the C3 and C15 stereogenic centers, thus these
metabolites can be grouped into one of two categories:
dihydrogranaticin (DHGRA), which display the 3R,15S
configuration, or actinorhodin (ACT), which display the
3S,15R configuration (Figure 3).[177,178]
The formation of enantiomerically opposite stereocenters
in the ACT and DHGRA families has led to the isolation of
early stage enantiomeric intermediates from different sour-
ces. Analysis of the numerous gene clusters (act, kal, nnm, gra,
etc.) that have been identified led to the identification of two
enantioselective ketoreductases. As shown in Scheme 11,
RED1/2 stereospecifically reduces the carbonyl functionality
in the bicyclic intermediate, thereby setting the C3 config-
uration.[178] In ACT biosynthesis, the S configuration is
established by act-VI-ORF1 (RED1),[179] whereas the R con-
figuration is established in dihydrogranaticin (DHGRA)
biosynthesis by the completely unrelated gra-ORF6 ketor-
eductase RED2.[177,180] These two enzymes show a remarkable
difference in their substrate specificities as well as in their
three-dimensional structures and catalytic mechanisms; how-
ever, both recognize the same substrate motif of the bicyclic
intermediate.[178a] Subsequent cyclization and reduction of this
intermediate results in the formation of the respective
Table 8: (Continued)
Quinone Species Biological activity
Streptocarpus dunni[152]
()-8-hydroxydunnione
[a] For species and biological activity that do not have a reference, please see the Review by Nicolau and co-workers (Ref. [151]).
Figure 2. Nactins and the monomeric units that make up the macro-
tetrolide antibiotics.
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Table 9: Enantiomeric polyketides.
Polyketide Species Biological activity





Streptomyces griseus,[155] Streptomyces spec. JA 5909-1[156]




Streptomyces rosa var. notoensis OS3966[160] antibiotic[160]
Nocardia sp. (bacteria)[161] antibiotic[161]
(+)-nanaomycin A
()-nanaomycin A Streptomyces rosa var. notoensis OS3966[162] antibiotic,[162] antifungal,[162] antimy-
coplasma activity[162]
Cercospora taiwanensis,[163] Fusarium larvarum,[163] Grignardia laricina,[163] Gyro-
stroma missouriense (fungus),[163] Helicascus kanaloanus (marine fungus),[164]
unidentified fungus[163]
(+)-mellein
()-mellein Aspergillus melleus (fungus),[163] Aspergillus ochraceus (fungus),[163] Aspergillus oniki
(fungus),[163] Camponotus spp.,[163] Cornitermes spp.,[163] Grapholithia molesta
(oriental fruit moth),[163] Hypoxylon spp.,[163] Lasiodiplodia theobromae
(fungus),[163] Marasmiellus ramealis (twig parachute mushroom),[163] Pestalotia
ramulosa (fungus),[163] Rhytidoponera metallica (green-head ant),[163] Septoria
nodorum (fungus)[163]
hepatitis C inhibitor,[165a] antibacter-
ial,[165b] antiviral,[165b] phytotoxic[165b]
Dermocybe kula (fungus)[166] major orange-red fungal pigment[166]
(+)-dermolactone
()-dermolactone Dermocybe kula[166] minor orange-red fungal pigment[166]
Verticillium dahliae (fungus),[167] Phialophora lagerbergii (fungus),[168] Scytali-
dium sp.[169]
(+)-scytalone
()-scytalone Phialophora lagerbergii,[168] Scytalidium sp.[169]




(1R,3R)- austrocortilutein Dermocybe sp. WAT 20934[172]
Dermocybe splendida,[170] Dermocybe sp. WAT 20934,[172] Dermocybe sp. WAT
21568[172]
antibiotic,[171] fungal pigment (yellow-
D. splendida)[172]
(1S,3R)- austrocortilutein
(1R,3S)- austrocortilutein Dermocybe sp. WAT 21567,[172] Dermocybe sp. WAT 20934[172]
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enantiomeric intermediates (S)-DNPA and (R)-DNPA. The
advanced BIQ natural products, such as actinorhodin and
DHGRA, are derived from these chiral intermediates.
5. Alkaloids
Alkaloids make up a vast and structurally diverse group of
nitrogenous metabolites that are isolated from plants, bac-
teria, fungi, and animals.[3] This family of natural products can
be further classified into subgroups, which are based on the
handful of a-amino acids that the alkaloids are derived from,
mainly lysine, ornithine, phenylalanine, tyrosine, and trypto-
phan. In addition to these primary building blocks, mevalo-
nate and acetate also serve as important starting points in the
biosynthesis of alkaloids.
Pharmacologically, alkaloids display myriad bioactivities
and are often used as medications, as recreational drugs, or in
entheogenic rituals.[181] Morphine, caffeine, and psilocin (a
mushroom hallucinogen) are common and well-known bio-
active examples of alkaloids. Several lesser-known alkaloids
are also biologically active and display anticancer, antibacte-
rial, anthelmintic, or anti-inflammatory activity.[182]
The occurrence of enantiomeric alkaloids in nature is
known; however, they are generally produced and isolated as
racemic or scalemic mixtures. As observed with the lignans,
many of the advanced alkaloid metabolites are produced in
optically pure form, but the metabolites produced in the early
stages of alkaloid biosynthesis are often isolated as enantio-
meric mixtures. Select examples of these enantiomeric
alkaloids are discussed below.
Scheme 10. Proposed stereocomplimentary pathways for the biogenesis of (+)- and ()-nonactic acid.[155i] NEA=2-methyl-6,8-dihydroxynon-(2E)-
enoic acid.
Scheme 11. Proposed enantioselective biosynthetic pathways of actino-
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5.1. Manzamine Alkaloids
The manzamines are a growing class of b-carboline-
containing cytotoxic marine sponge alkaloids that display an
unusual polycyclic diamine system.[183] These natural products
were first identified in the late 1980s and were found to have
a diverse range of biological activities, including, but not
limited to, antitumor, anti-inflammatory, insecticidal, and
antiparasitic activity. Several of these natural products also
display promising anti-infective activity against malaria and
Mtb.[183]
The diversity in the location (Okinawa, the Philippines,
Indonesia, the Red Sea, Italy, South Africa, and Papua New
Guinea) and genera of sponges (Amphimedon sp. and
Acanthostrongylophora) responsible for the production of
manzamine alkaloids is widely believed to be a result of
a symbiotic relationship between these sponges and common
or closely related microorganisms, which may account for the
generation of manzamine enantiomers.[183] To date, only a few
enantiomeric manzamine natural products have been isolated
(Table 10) and the biosynthetic formation of these enantio-
meric metabolites is currently under investigation.
Within this class of alkaloids, the isolation of both
enantiomers of 8-hydroxymanzamine A, manzamine F, and
keramaphidin B have been reported, along with the enantio-
meric congeners, ircinal A and B as well as ircinol A and B.[183]
Interestingly, ircinols A and B are enantiomeric congeners of
the alcoholic forms of ircinal A and B, respectively, and they
also represent the first manzamine alkaloids to possess the
opposite absolute configuration to that of manzamines A and
B.[184] As shown in Figure 4, one enantiomer of keramaphi-
din B, ircinals A and B, and manzamines A and B all belong
to one configurational series, while the other enantiomer of
keramaphidin B and ircinols A and B, ingenamine, and
ingamine A contain the opposite absolute configuration,
and thus make up a second enantiomeric series.
Since it is likely that sponge-associated microbes produce
the manzamines, efforts to elucidate the biosynthetic pathway
of these unique compounds is limited.[183] The identification of
bacterial isolates from a manzamine-producing sponge, as
well as culturing the bacteria responsible for these trans-
formations are limiting factors to completely understanding
the biosynthesis of the manzamines. However, following the
identification, isolation, and screening of numerous microbes
frommanzamine producing sponges, the biotransformation of
both 8-hydroxymanzamine A to manzamine A[185] and ent-8-
hydroxymanzamine A to the known metabolite ent-12,34-
oxamazamine F[186] have been successfully carried out
(Scheme 12).
5.2. Indole Alkaloids
Indole alkaloids are natural products derived from
tryptophan and make up one of the largest groups of alkaloid
secondary metabolites.[193] Biogenetically, this class of alka-
Table 10: Enantiomeric manzamine alkaloids.
Manzamine Species Biological activity
Indonesian sponge Pachypellina sp.,[187] Okinawan sponge Xestospongia sp.,[188]
Okinawan sponge Amphimedon sp.[188]
anticancer[183]
(+)-8-hydroxymanzamine A
()-8-hydroxymanzamine A unidentified Indo-Pacific sponge (family Petrosiidae, order Haplosclerida)[189] anticancer,[183] antimalarial[183]
Xestospongia sp.[190] antimicrobial,[183] anticancer[183]
(+)-manzamine F
()-manzamine F unidentified Indo-Pacific sponge (family Petrosiidae, order Haplosclerida)[189] activity against Mycobacterium
tuberculosis[183]
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loids can be divided into two structural categories: isopre-
noid-containing natural products and non-isoprenoid-con-
taining alkaloids. The latter group is comprised of simple
indole derivatives, simple derivatives of b-carboline, and
pyrroloindole alkaloids.[194] The isoprenoid alkaloids contain
terpenoid structural elements derived from DMAPP and/or
IPP.[195] The formation of enantiomeric indole alkaloids has
been documented within the various subdivisions of the more
complex isoprenoid alkaloids, as outlined in Section 5.2.1 and
5.2.2.
5.2.1. Terpenoid Indole Alkaloids
Terpenoid alkaloids are often found in plant species




from the family Apocyna-




the terpenoid indole alka-
loid biosynthetic pathway
in Catharanthus roseus has
been extensively studied.
More than 20 enzymatic
steps have been identified
in this intricate biosynthet-
ic pathway, which leads
from the primary metabo-
lites to the structurally
complex antineoplastic
agent vinblastine. As is
the case of many secon-
dary metabolites, the
advanced late-stage intermediates, such as vinblastine and
vincristine, are produced and isolated as a single enantiomer,
whereas the early stage metabolites are sometimes produced
as scalemic mixtures. As shown in Table 11, these enantio-
meric metabolites often occur in separate species as a single
enantiomer. While the overall biosynthesis of terpenoid
indole alkaloids is fairly well understood, the biogenesis of
enantiomeric metabolites is not currently known.
5.2.2. Reverse Prenylated Indole Alkaloids
The unique and diverse family of reverse prenylated
indole alkaloids containing a bicyclo[2.2.2]diazaoctane ring
system has been the subject of extensive research because of
their complex molecular structures and wide array of
biological activities.[203] Members of this family have been
isolated from both marine and terrestrial sources, most
notably from the genera Aspergillus and Penicillium, and
have been reported to display insecticidal, anthelmintic,
calmodulin-inhibitory, antibacterial, and antitumor proper-
ties. The recent identification of enantiomeric metabolites
from related Aspergillus species has sparked interest in
elucidating the biosynthetic pathway of the stephacidin and
notoamide family of reverse prenylated indole alkaloids.
In 2009, Tsukamoto and co-workers isolated the known
natural product (+)-stephacidin A[204] from marine-derived
Aspergillus sp. MF297-2, along with several new metabolites,
later named the notoamides.[205] Shortly following the iso-
lation of the stephacidins and notoamides from Aspergil-
lus sp. MF297-2, Gloer and co-workers isolated the corre-
sponding enantiomers from the terrestrial-derived fungus
Aspergillus versicolor NRRL 35600.[206] These enantiomeric
alkaloids (Table 12) are hypothesized to arise by a biosyn-
thetic Diels–Alder reaction, which implies that each Asper-
gillus species possesses enantiomerically distinct Diels–Alder-
ases. Furthermore, each fungal culture must also possess
enantiomerically distinct oxidases responsible for the face-
Figure 4. The two enantiomeric series of manzamine alkaloids.





4823Angew. Chem. Int. Ed. 2012, 51, 4802 – 4836  2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
Table 11: Enantiomeric indole alkaloid metabolites.[a]
Indole alkaloid Species Biological activity
Amsonia tabernaemontana (Eastern bluestar),[197] Amsonia angustifolia, Rhazya stricta,
Tabernaemontana riedelii, Vinca difformis (intermediate periwinkle), Macoubea guianensis[198]
(+)-vincadifformine
()-vincadifformine Vinca minor (dwarf periwinkle), Vinca difformis, Rhazya stricta, Tabernaemontana riedelii,
Macoubea guianensis[198]
Vinca minor, Amsonia tabernaemontana, Amsonia angustifolia, Macoubea guianensis[198]
(+)-vincadine
()-vincadine Amsonia tabernaemontana, Amsonia angustifolia, Macoubea guianensis





Vinca erecta, Pleiocarpa tubicina, Pleiocarpa pycnantha var. pycnantha, Stemmadenia donnell-
smithii
(+)-quebrachamine
()-quebrachamine Aspidosperma quebracho-blanco (South American tree), Aspidosperma chakensis, other
Aspidosperma spp., Gonioma kamassi, Hunteria elliotii, Rhazya stricta
Aspidosperma dasycarpon
(+)-apparicine
()-apparicine Aspidosperma olivaceum, other Aspidosperma spp., Catharanthus ovalis (rosy periwinkle),
Catharanthus roseus (Madagascar periwinkle), Pandaca ochrascens, Pandaca eusepala, Ervata-
mia heyneana, Tabernaemontana cumminsii, Schizzygia caffaeoides
anticancer, antibac-
terial, antiviral
Hunteria eburnea, Amsonia tabernaemontana, Vinca minor
(+)-eburnamonine




()-akuammicine Picralima nitida, Alstonia scholaris (blackboard tree), other Alstonia spp., several Vinca spp.,
Rauwolfia volkensii, Hunteria congolana, Catharanthus microphyllus, Cabucala erythrocarpa,
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selective pinacol-type rearrangement to form the spirooxin-
dole moiety observed in notoamide B and versicolamide B.
Thus, Williams and co-workers proposed that the stephacidin
and notoamide family shared a common biosynthetic pathway
and that the enantiomeric formation of these alkaloids was
due to a key enantiodivergent step in an otherwise common
biogenetic pathway.[203] This study was further aided by the
identification and characterization of the Aspergillus sp.
MF297-2 and the Aspergillus versicolor NRRL35600 gene
clusters,[207] as well as parallel precursor incorporation studies
with both fungal cultures.[208]
A biosynthetic pathway has been proposed on the basis of
results from genome mining and tracer studies.[207,208] As
shown in Scheme 13, the pathway branches into at least two
possible directions from the proposed pivotal intermediate
notoamide S.[209] Formation of the pyranoindole to yield
notoamide E results in the biosynthesis of notoamide C, 3-
epi-notoamide C, and notoamide D[208a,b] by the proposed
enzyme NotB. However, notoamide S could also undergo
a two-electron oxidation by either NotD or NotH to give the
achiral azadiene, which acts as the enantio-diverging point in
the biosynthesis. The achiral azadiene can undergo a stereo-
selective [4+2] cycloaddition to yield either (+)-notoamide T
in Aspergillus sp. MF297-2 or ()-notoamide T in Aspergillus
versicolor. From these putative intermediates, cyclization to
form the pyranoindole ring system would furnish the enan-
tiomeric pair of stephacidin A. It was ascertained through
precursor incorporation studies of 13C-labeled ()-stephaci-
din A with both A. versicolor and Aspergillus sp. MF297-2
that face-selective oxidative enzymes (currently presumed to
be flavoenzymes) are present in both fungal cultures, as
evident by the enantioselective conversion of stephacidin A
into notoamide B.[208c] In A. versicolor NRRL 35600, this
oxidase is responsible for the biosynthetic conversion of ()-
stephacidin A into (+)-notoamide B, while a stereochemically
Table 11: (Continued)




Nitraria schoberi (nitre bush)[193, 202]
()-nitrarine
[a] For species and biological activity that do not have a reference, see the Dictionary of Alkaloids (Ref. [193]).
Table 12: Enantiomeric reverse prenylated indole alkaloids.
Reverse prenylated indole alkaloid Species Biological activity
Aspergillus sp. MF297-2 (fungus),[205] Aspergillus ochraceus (fungus)[204] anticancer[204]
(+)-stephacidin A
()-stephacidin A Aspergillus versicolor (fungus)[206]
Aspergillus versicolor[206]
(+)-notoamide B
()-notoamide B Aspergillus sp. MF297-2[205]
Aspergillus versicolor[206]
(+)-versicolamide B
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complementary oxidase in the marine-derived Aspergillus sp.
MF297-2 converts (+)-stephacidin A into ()-notoamide B.
It is significant that the oxidation must occur from distinct
enantiotopic faces of the indole ring system in each of these
respective oxidation reactions of the 2,3-disubstituted indole
moiety of stephacidin A, and we currently doubt that this is
accomplished by identical enzymes. More precisely, the
oxidation of (+)-stephacidin A into ()-notoamide B must
occur exclusively from the pro-R face of the indole in
Aspergillus sp. MF297-2, and the oxidation of ()-stephaci-
din A into (+)-notoamide B in Aspergillus versicolor must
occur exclusively from the pro-S face of the indole. To date,
the diastereomeric oxindoles that would result from a puta-
tively non-face-selective oxidation have not been detected. Of
further intrigue was the observation that Aspergillus sp.
MF297-2 produces ()-versicolamide B and that Aspergillus
versicolor produces the enantiomer (+)-versicolamide B. The
putative precursor to versicolamide B, C6-epi-stephacidin A,
has not yet been detected as a natural metabolite, but its
existence in each fungus is anticipated. Synthetic samples of
this substance have been prepared and are under investiga-
tion.
In an effort to understand the enzymatic basis for the
biosynthesis of enantiomeric alkaloid natural products we
have pursued total genome sequencing and mining of the
stephacidin/notoamide pathways from two fungal strains. The
marine Aspergillus sp. MF297-2 strain generates ()-noto-
amide B, whereas the terrestrial Aspergillus versicolor strain
Scheme 13. Putative enantiodivergent biosynthesis of stephacidin A and the notoamides. IMDA= intramolecular Diels–Alder reaction.
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generates the enantiomer (+)-notoamide B. The key chiral
determinant is hypothesized to reside within the presumed
intramolecular Diels–Alderase enzyme. We have found the
molecular architecture (e.g. gene placement and direction-
ality of transcription) of these pathways to be remarkably
similar, with > 70% identity of nucleotide sequences across
the 35 kb gene clusters. The corresponding high level of
amino acid sequence similarity suggests that subtle variation
in the active-site sequence plays a critical role in controlling
the chirality and in accommodating the corresponding
enantiomeric substrates for downstream assembly and tailor-
ing reactions.
5.3. Quinolizidine (Lupine) Alkaloids
Quinolizidine alkaloids, often referred to as lupine (or
lupin) alkaloids, are secondary metabolites found in a wide
variety of leguminous plant and tree species.[211] There are
over 550 known quinolizidine alkaloids, with many of these
secondary metabolites occurring in the subfamily Papilionoi-
deae of the Fabaceae. They are especially abundant in the
families Genisteae, Sophoreae, and Thermopsideae. Biolog-
ically, the lupine alkaloids have been implicated in plant–
herbivore interactions, with many of these alkaloids display-
ing toxic and/or teratogenic properties to livestock.[212]
The first reported isolations of the lupine alkaloids
revealed that in many cases both enantiomers of a given
alkaloid occur in nature;[213] however, after further examina-
tion, many of the proposed racemates were found to actually
occur as optically pure isoforms.[214] This Review will only
focus on select major enantiomeric lupine metabolites that
are known to occur in nature. Several of these metabolites are
shown in Table 13, along with a limited listing of the
respective sources of isolation.
Unfortunately, biosynthetic studies of enantiomeric
lupine alkaloids are rather limited. Independently, the
research groups of Spenser, Robins, and Wink demonstrated
that the quinolizidine alkaloids are biosynthesized from lysine
via a symmetrical cadaverine intermediate. A lysine decar-
boxylase that converts lysine into cadaverine was isolated
from lupine cell cultures and intact plants; however, late-stage
biosynthetic conversions remain elusive.[222] Through feeding
studies using labeled precursors, both lysine and cadaverine
have been shown to incorporate into ()-sparteine, (+)-spar-
teine, and (+)-lupanine (Scheme 14).[223]
5.4. Piperidine and Pyridine Alkaloids
Both piperidine and pyridine alkaloids are secondary
metabolites containing a six-membered heterocyclic ring
system with a nitrogen-containing nucleus, in which this
heterocycle is saturated in piperidine alkaloids and unsatu-
rated in pyridine alkaloids. Simple piperidine and pyridine
natural products are generally associated with toxic alkaloids,
as observed in one of the most well-known examples of
a pyridine alkaloid, nicotine.[8] Similarly, several piperidine
alkaloids are known poisons produced by the poison hemlock,
Conium maculatum.[224] Many of the piperidine and pyridine
alkaloids are known teratogenic agents,[225] and the ingestion
of plants that produce these natural products by pregnant
livestock can result in newborns with multiple congenital
contractures and/or cleft palates.[226] As shown in Table 14,
enantiomeric metabolites of these alkaloids are particularly
rare, but those that are known are produced by a variety of
plant sources. Several of these metabolites, such as ammo-
dendrine, are produced as a nearly racemic mixture by
a single species, whereas other metabolites occur as partial
racemates.[6b] For example, the S or () isoform of nicotine
generally makes up more than 95% of the natural product
produced by tobacco.[8]
While significant effort has been put forth towards
elucidating the biosynthetic pathway of these metabo-
lites,[8,227] the enantiomeric biogenesis of the piperidine and
pyridine alkaloids has not been investigated. As found with
nicotine, biosynthetic studies have focused on the biogenesis
of the major enantiomer, in this case ()-nicotine, and as
such, there are currently no known explanations for the
formation of (+)-nicotine. Furthermore, the characterization
of enzymes responsible for the biosynthesis of piperidine and
pyridine alkaloids, such as coniine, demonstrate a high
substrate- and stereospecificity, and thus the biosynthesis of
only one enantiomer is known.[182] To date, no enantiomeri-
cally opposite enzymes responsible for the biosynthesis of
pyridine or piperidine alkaloids have been identified.
5.5. Benzylisoquinoline Alkaloids
Benzylisoquinoline alkaloids (BIA) are a structurally
diverse group of nitrogen-containing plant secondary metab-
olites consisting of more than 2500 defined structures and are
found mostly in five plant families: the Papaveraceae,
Fumariaceae, Ranunculaceae, Berberidaceae, and Menisper-
maceae.[196c,231] Structurally, the benzylisoquinoline natural
products can be further divided into numerous groups,
such as the aporphines, phthalideisoquinolines, morphin-
ans, protoberberines, and pavines.[232] Benzylisoquinoline
alkaloids are widely known to be produced by opium
poppy (Papaver somniferum), and are well known for their
wide range of biological activity and pharmaceutical
importance. This group of alkaloids include morphine
and codeine (two well-known analgesics), papaverine (a
muscle relaxant), noscapine (an antitumor agent), and
sanguinarine (an antibiotic).[231b,233] The biosynthesis of
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and as such most of the biogenesis is understood at an
enzymatic level.[196c,231–233] Furthermore, as shown in Table 15,
the occurrence of enantiomeric benzylisoquinolines is known;
however, the biosynthetic formation of all these enantiomers
is not fully understood.
Biosynthetically, benzylisoquinoline alkaloids are all
derived from l-tyrosine along a basic benzylisoquinoline
pathway.[232,233] As shown in Scheme 15, the first committed
step in the BIA biosynthesis is the asymmetric Pictet–
Spengler condensation of tyrosine-derived dopamine and
para-hydroxyphenylacetaldehyde (4-HPAA) in the presence
of norcoclaurine synthase (NCS) to yield optically pure (S)-
norcoclaurine.[231] (S)-norcoclaurine is converted into opti-
cally pure (S)-reticuline through four enzymatic transforma-
tions. This intermediate serves as a vital branching point to
the various benzylisoquinoline alkaloids, many of which
display the same configuration as (S)-reticuline; however,
the promorphinan and morphinan subgroup of BIAs contain
the opposite (R) configuration.[232] These alkaloids are
derived from (R)-reticuline, which arises from the inversion
of the configuration of (S)-reticuline by way of oxidation and
reduction with 1,2-dehydroreticuline synthase (DRS) and 1,2-
dehydroreticuline reductase (DRR).[235]
Early on, the biogenesis of some of the R-configured
benzylisoquinoline alkaloids had been proposed to arise via
(R)-reticuline; however, tracer incorporation studies have
shown that this is not the case.[236] Based on the lack of
incorporation of (R)-reticuline into the more advanced R-
configured BIAs, it has been suggested that the formation of
the R series of metabolites arise from a stereochemical
inversion of the S enantiomer by enzymatic oxidation and
reduction. Similar to the formation of enantiomeric reticuline,
other BIA enantiomers, such as (R)- and (S)-canadine, are
formed from an inversion of configuration. In the case of
Table 13: Lupine alkaloid enantiomers.[a]
Lupine alkaloid Species Biological activity
Cytisus caucasicus, Lupinus pusillus (rusty lupine), Genista monosperma (bridal broom), Pelargonium acutifolia,
Pelargonium longifolia, Sophora pachycarpa, Ammodendron spp., Baptisia spp. Chamaecytisus proliferus,
Adenocarpus hispanicus, Hovea linearis (common Hovea),[214] Lygos raetam var. sarcocarpa,[215] Lupinus albus
(white lupine),[216] Genista lydia (hardy dwarf broom)[217]
highly toxic
(+)-sparteine
()-sparteine Cytisus scoparius (Scotch broom), Lupinus spp., Adenocarpus spp., Piptanthus nanus, Sarothamnus spp.,
Chamaecytisus proliferus, Corothamnus rectipilosus,[215] Chamaecytisus austriacus,[216] Genista lydia[217]
oxytoxic,
antiarrhythmic
Lupinus albus, Lupinus termis, Podalyria buxifolia, Virgilia capensis, Cytisus scoparius, other Cytisus spp., Cadia
purpurea, Ammopiptanthus mongolicus, Thermopsis chinensis (Chinese bush pea), Leontice spp., Genista spp.,
Templetonia spp. Chamaespartium sagittale,[215] Corothamnus rectipilosus,[215] Genista rumelica,[215] Genista
sessilifolia,[215] Chamaecytisus austriacus,[216] Genista lydia[217]
toxic to livestock
(+)-lupanine
()-lupanine Lupinus albus, Lupinus termis, Podalyria buxifolia, Virgilia capensis, Lupinus pusillus, Lupinus macounii, Baptisia
versicolor, Podalyria calyptrata (water blossom pea), Ammodendron spp., Leontice smirnovii, Leontice
eversmannii, Lygos raetam var. sarcocarpa,[215] Genista lydia,[217] Clathrotropis glaucophylla[218]
toxic to livestock
Lupinus spp.,[211a] Lupinus pusillus[219]
(+)-b-isosparteine
()-b-isosparteine Lupinus pusillus,[211a,220] Lupinus sericeus (silky lupine),[221] Lupinus argenteus stenophyllus (silvery lupine),
Lupinus solosericeus, Sophora secundiflora (Texas mountain laurel)
Lupinus caudatus (tailcup lupine), Lupinus corymbosus
(+)-thermopsine
()-thermopsine Thermopsis lanceolata (golden banner), Thermopsis rhombifolia (Buffalo bean), Sophora secundiflora
Ormosia panamensis (Coronil), Piptanthus nanus
(+)-ormosanine
()-ormosanine Podopetalum ormondii, Ormosia semicastrata, Ormosia jamaicensis, Piptanthus nanus
Hovea linearis, Templetonia retusa (cockies tounge), Ormosia semicastrata, Ammopiptanthus mongolicus
(+)-piptanthine
()-piptanthine Hovea linearis, Templetonia retusa, Ormosia semicastrata, Ammopiptanthus mongolicus, Piptanthus nanus
[a] For species and biological activity that do not have a reference, see the Dictionary of Alkaloids (Ref. [193]).
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enantiomeric canadine, (S)-canadine is first oxidized by (S)-
tetrahydroxyprotoberberine oxidase (STOX) to form berber-
ine, which is subsequently reduced by berberine reductase to
yield (R)-canadine (Scheme 16).[236,237]
Unfortunately, substantial information is lacking on the
biosynthesis of all of the enantiomeric BIAs. As seen in the
elucidation of the enantiomeric nicotine biosyn-
thetic pathway, the biogenesis of only one enantio-
mer of the BIA natural products is understood, as is
the case with (S)-scoulerine and (+)-salutari-
dine.[233] To date, no enantiomerically opposite
enzymes in the biosynthesis of the benzylisoquino-
line alkaloids have been isolated.
6. Summary and Outlook
As demonstrated in this Review, the formation
of enantiomeric natural products by nature is not as
uncommon as one might have initially expected.
While the number of enantiomeric natural products
that have been discovered to date represent a small
fraction (less than 1%) of the biosphere’s metab-
olome, it is clear that biogenetic mechanisms to
create distinct enantiomers are widely expressed.
Many puzzles and stereochemical anomalies
remain and provide a fertile area of future inquiry
and discovery. A substantial body of research has
been carried out over the years to attempt to
understand the biogenesis of some of the enantiomeric
metabolites, but our level of understanding remains in its
infancy.
The points at which an enantiodivergence may occur in
a biosynthetic pathway vary. For example, in the terpene
cyclases (pinene, limonene; see Scheme 2), a simple precur-




Genista sphaerocarpa, Ammodendron conollyi, Ammodendron spp., Sophora franchetiana,
Sophora tomentosa (yellow necklace pod),[228] Coelidium fourcadei, Lupinus formosus (summer
lupine),[225a,b] Lupinus varius,[225a] Lupinus hirsutus[225a]
teratogen[225]
(+)-ammodendrine
()-ammodendrine Ammodendron conollyi, Ammodendron spp., Sophora franchetiana, Sophora tomentosa,[228]
Coelidium fourcadei, Lupinus formosus,[225a,b] Castilleja miniata (giant red Indian paint-
brush)[225a]
teratogen[225]




()-anabasine Nicotiana glauca,[225d] Anabasis aphylla,[230] Aphaenogaster subterranea,[229] Aphaenogaster
miamiana,[229] Messor sanctus (ant)[229]
teratogen[225d]
Conium maculatum (poison hemlock)[225c] toxic to livestock[225c]
(+)-coniine
()-coniine Conium maculatum[225c] toxic to livestock[225c]
Nicotiana tabacum (cultivated tobacco)
weakly binds to nicotinic acetyl-
choline receptors[8]
(+)-nicotine
()-nicotine Nicotiana tabacum, other Nicotiana spp., Asclepias syriaca (common milkweed), Lycopodium
spp., Equisetum arvense (field horsetail), Sedum acre (golden stonecrop)
incredibly reactive at nicotinic
acetylcholine receptors[8]
[a] For species and biological activity that do not have a reference, see the Dictionary of Alkaloids (Ref. [193]).
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sor, such as geranyl diphosphate, can give rise to the two
enantiomeric forms in the first committed step of the pathway.
In other instances, the enantiodivergent step occurs later in
the pathway, as appears to be the case with the stephacidins
and notoamides. With recent advances in whole genome
sequencing, proteomics, metabolomics, and genome mining,
significant leaps in unraveling many of these intriguing
biosynthetic pathways are expected to accelerate. In many
cases, enantiomeric metabolites arise from two distinct
enzymes that function in an enantiodivergent and distinct
mechanistic manifold, such as the (+)- and ()-limonene
synthases. On the other hand, the generation of both
enantiomers from a single enzyme may be due in part to
a lack of enzyme substrate- and stereospecificity, which was
observed in the biosynthesis of (+)-carvone by (+)-limonene-
6-hydroxylase and (+)-trans-carveol dehydrogenase. In sev-
eral examples, the biosynthetic formation of one enantiomer
is understood at an enzymatic level, while the biogenesis of
the minor enantiomer remains unknown. Furthermore, the
enantioselective catabolism of an initially produced racemic
metabolite remains an additionally valid paradigm that has
been little investigated. As more and more natural metabo-
lites are discovered, despite the recent, severe cutback in
research funding for the isolation and structural elucidation of
natural products, it is almost a certainty that additional
families of enantiomeric natural substances will be discov-
ered. The myriad of genetic and biochemical mechanisms
controlling and leading to the phenotypic expression of
enantiomeric natural substances will continue to tantalize the
imagination. The impact of next-generation sequencing and
bioinformatic tools to mine natural product biosynthetic
genes and assemble pathways from diverse microbial and
Table 15: Enantiomeric benzylisoquinoline alkaloid secondary metabolites.[a]
Benzylisoquinoline alkaloid Species Biological activity
Annona reticulata (wild sweetsop), Phylica rogersii, Papaver somniferum (opium poppy)
(+)-reticuline
()-reticuline Romneya coulteri var. trichocalyx (Coulter’s Matilija poppy)




Sinomenium acutum, Corydalis spp., Gacium spp., Nandina spp., Croton salutaris, Stephania
yunnanensis[234]
Corydalis tuberosa, Corydalis cava
(+)-scoulerine
()-scoulerine many Corydalis spp., Erythrina orientalis, Bocconia frutescens (tree poppy), Glaucium spp.,







()-canadine Hydrastis canadensis (goldenseal), several Corydalis spp. analgesic,
hypotensive
[a] For species and biological activity that do not have a reference, see the Dictionary of Alkaloids (Ref. [193]).
Scheme 16. Biosynthesis of enantiomeric canadine.
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plant species will have an enormous impact on future
investigations. Moreover, the continued development of
molecular tools to engineer gene-disruption mutants and for
heterologous expression will provide new insights into the
details of natural product assembly and functional group
elaboration. Moreover, the ability to clone, overexpress, and
purify biosynthetic enzymes from diverse microbial and plant
species will allow in vitro studies of the metabolic pathway
components with natural and unnatural substrates. These
powerful approaches will provide access to even more
chemical diversity from which exciting biological activities
and potential drug leads might be identified.
Finally, the genetic mechanisms resulting in the formation
of enantiomeric natural products has yet to be analyzed from
an evolutionary molecular genetics perspective.[238] In this
regard, key questions remain about the mechanism(s) by
which an enzyme making one enantiomeric form evolves to
produce the enantiomeric form. Does the process, for
example, require a gene duplication event, where one of the
paralogues can be freed from selective constraints, thus
allowing it to evolve by genetic drift to acquire multiple
substitutions? Or, alternatively, can a single orthologue
evolve this ability independently from different ancestral
forms of an enzymatic function? Based on the examples
covered here in this Review, it appears that both may occur. A
related question in cases where the two stereoselective
enzymes have evolved from a common ancestor is, what is
the ancestral state—an enzyme that produces a (partially)
racemic mixture or an enzyme that produces one pure
enantiomer? It is interesting to note that instances in which
an enzyme produces both enantiomers are known, and also
cases in which one enantiomer is produced in great excess
over the other. Can the latter be thought of as an example of
an intermediate state in the evolution of an enzyme from
a nonselective form to a purely selective form? This
provocative question merits thought and investigation
because, of course, if evolution does not proceed from one
form of the enzyme to the other (i.e., from a ()-producing
form to a (+)-producing form) in a single mutation (e.g
a single amino acid substitution in an active site) but rather
through a transition requiring multiple amino acid changes,
then all of the intermediate states have to be both possible
functionally and also not be deleterious to the producing
organism. Thus, the ancestral state and the number of changes
in a protein required for the transition from one antipodal
product to the other are fundamental questions that have
been little, if at all, studied. Another equally interesting
question concerns the adaptive significance of these stereo-
selective transitions, and this field is probably wide open.
Phylogenetic and bioinformatic analysis of enantiomeric
enzymes holds the promise of revealing mechanistic signa-
tures of their functional evolution, including the roles of gene
duplication, exon shuffling, natural selection, and genetic
drift. What is particular tantalizing about enzymes that
generate opposite enantiomers of a particular structure is
the ability to study many independent cases of this evolu-
tionary process—a rare opportunity in molecular evolution.
Such an investigation has the potential of revealing general-
ities about the evolution of protein structure/function for this
subtlest of possible changes in natural product chemistry.
We are grateful to the National Institutes of Health for financial
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